Paul A Barsanti

Title: Paul A. Barsanti: Innovator in Pharmaceutical Compounds

Introduction

Paul A. Barsanti is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for specific enzymes. His work is characterized by a focus on innovative solutions that address critical health challenges.

Latest Patents

Paul A. Barsanti holds a patent for "Piperazine substituted indazole compounds as inhibitors of PARG." This patent describes compounds of Formula (I) or a pharmaceutically acceptable salt thereof. The compounds are recognized for their utility as Poly ADP-ribose glycohydrolase (PARG) inhibitors, which play a crucial role in various biological processes. The patent outlines additional utilities and advantages of these compounds, showcasing Barsanti's innovative approach to drug development.

Career Highlights

Barsanti is currently associated with Ideaya Biosciences, Inc., a company that focuses on precision medicine and innovative therapeutic solutions. His work at Ideaya has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Barsanti has collaborated with esteemed colleagues, including Michael Patrick Dillon and Firoz Ali Jaipuri. These collaborations have fostered a dynamic environment for innovation and have led to advancements in their respective fields.

Conclusion

Paul A. Barsanti exemplifies the spirit of innovation in the pharmaceutical industry through his patent and contributions at Ideaya Biosciences, Inc. His work continues to impact the development of therapeutic solutions that address significant health issues.